|Raymond J. Land|
Formerly Senior Vice President and Chief Financial Officer Clarient, Inc.
A member of the board of directors for Anika Therapeutics, Inc. since 2006, Raymond J. Land is formerly the Senior Vice President and Chief Financial Officer of Clarient, Inc., an advanced molecular diagnostics company. Mr. Land was previously Senior Vice President and Chief Financial Officer at Safeguard Scientifics, Inc. from June 2007 to May 2008. Prior to Safeguard Scientifics, Mr. Land held executive management and chief financial officer positions at Medcenter Solutions, Inc., a global pharmaceutical marketing company, and Orchid Cellmark, a leading provider of identity DNA testing services. Mr. Land previously served as Senior Vice President and Chief Financial Officer for Nasdaq-traded Genencor International, Inc., a diversified biotechnology company focusing on bioproducts and healthcare from 1997 until its acquisition by the global company Danisco in April 2005. From 1991 to 1996, he served as Senior Vice President and Chief Financial Officer for publicly traded West Pharmaceutical Services, Inc. Previously, Mr. Land was with Campbell Soup Company, Inc., where for nine years he held increasingly senior financial positions and also served as General Manager of the frozen food division. Prior to joining Campbell Soup, he was with Coopers and Lybrand for nine years. Mr. Land also serves as a board member for Mountain View Pharmaceuticals, and in February 2012 was appointed Chairman of the Board of BioAmber, Inc. He is a Certified Public Accountant and has a B.B.A. degree in accounting and finance from Temple University.